Advertising & Promotion for Medical Products Conference

Overview

The Advertising and Promotion for Medical Products (A&P) Conference congregates representatives from federal agencies, industry, patient-advocacy groups, and academics to explore government initiatives and priorities concerning medical product advertising and promotion, critical developments in the field, trends in enforcement and regulation, and new technologies. Diverse perspectives, engagement opportunities, and timely subject matter make this a truly unique program with great learning potential. 

Call for Proposals

FDLI invites you to submit a proposal for a session for the Advertising & Promotion for Medical Products Conference. Your submissions ensure that the most pertinent topics are covered. Topics should address issues and developments relating to advertising and promotion affecting the FDA-regulated medical products community.

Proposal Submission Guidelines

• Propose advanced-level topics.
• Provide important details and context: why the topic is important, who is affected, and relevant legislation, guidance, or news-worthy developments.
• Present a thoughtful title and speaker recommendations.
• As a neutral convener, FDLI prefers topics that include multiple perspectives, including government, industry, private attorneys, academics, and public interest.
• FDLI is committed to supporting, promoting, and celebrating diversity, equity, and inclusion in the food and drug law community. We encourage proposals addressing systematic or historical impacts on minority equity.

Submissions FAQ

• Q: Am I limited in the number of proposals I can submit?
  • A: Multiple submissions from the same person or organization are welcome – however, each proposal requires its own form.
• Q: How will my submission be reviewed?
  • A: All submissions are blinded before being reviewed by the Conference Planning Committee. All submissions are treated as recommendations, and proposals may be modified or combined by FDLI to best suit the needs of the conference.
• Q: Do all items in my proposal need to be in final form?
  • A: No–Your proposal does not need to be in final form. A proposal can and will likely be updated by the Committee to include the newest or most up-to-date information as relevant for the FDLI audience.
• Should I reach out to speakers I suggest in advance of submitting my proposal?
  • A: Suggested speakers should not be invited in advance – sessions are often combined and we cannot guarantee that suggested speakers will be included.
• Q: Can I email you my submission?
  • All submissions must be received through the submission portal.
• Q: If my topic is selected do I get to speak? Do I have to speak if my topic is selected?
  • A: Speaking opportunities are generally reserved for FDLI members. If your topic is selected, you will be invited to speak if you are interested; however, speaking is not a requirement to submit a topic.
• Q: If my topic is selected and I am chosen to speak, can I recommend a colleague from the same organization to participate as a speaker with me on a panel?
• Q: How will I know if my submission is accepted?
  • A: You will be notified of the status of your submission by late July.

Proposal Submission Timeline

• March 25: Call for Proposals opens
• May 24: Call for Proposals closes
• Those who submitted proposals will be notified of their submission’s status approximately three months before the conference date

Register

Early registration expires 7/31/2024

Sponsorship opportunities are available. Please let us know if you would like more information.

Katie Bond, Keller and Heckman LLP
Hannah R. Bornstein, Nixon Peabody LLP
Dominick P. DiSabatino, Sheppard Mullin Richter & Hampton LLP
Mark Gardner, Gardner Law, PLLC
Abraham Gitterman, Arnold & Porter LLP
Alan G. Minsk, Arnall Golden Gregory LLP
Anisa Mohanty, DLA Piper
Devaki Patel, Alston & Bird LLP
Nancy E. Taylor, Greenberg Traurig, LLP
Sara Wexler Koblitz, Hyman, Phelps & McNamara, PC
Heta Zaveri, Opus Regulatory, Inc.